Dr. Amanda Li graduated from Dalhousie University medical school in 2010, and completed her Pediatrics residency and Pediatric Hematology-Oncology fellowship at the University of British Columbia. Following this, she trained at the Children’s Hospital of Philadelphia in the field of Cancer Immunotherapy and Bone Marrow Transplant, with a clinical and research focus on using genetically engineered cell therapies in the treatment of hematologic malignancies.